Andreas Menrad
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 7
- Urology top 2%
- Hair Growth and Disorders 3
- Oncology top 5%
- Peptidase Inhibition and Analysis 3
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 4
- Immunology top 10%
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 3
-
- Angiogenesis and VEGF in Cancer 7
-
- Monoclonal and Polyclonal Antibodies Research 7
- Co-authors
- Michael SchirnerMartin R. SchneiderHans D. MenssenMeenhard HerlynRalf PausGerhard SiemeisterJens HoffmannDavid W. Speicher
- Journals
- Journal of Investigative Dermatology (3 papers)The FASEB Journal (2 papers)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Andreas Menrad
30 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 90
- Immunology and Allergy 162
- Urology 163
- Oncology 513
- Cancer Research 206
- Immunology 267
Countries citing papers authored by Andreas Menrad
This map shows the geographic impact of Andreas Menrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Menrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Menrad more than expected).
Fields of papers citing papers by Andreas Menrad
This network shows the impact of papers produced by Andreas Menrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Menrad. The network helps show where Andreas Menrad may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andreas Menrad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2014 | 3 | |
| 3 | 2011 | 58 | |
| 4 | 2009 | 130 | |
| 5 | 2008 | 8 | |
| 6 | 2005 | 81 | |
| 7 | 2005 | 37 | |
| 8 | 2004 | 1 | |
| 9 | 2004 | 46 | |
| 10 | 2002 | 36 | |
| 11 | 2002 | 83 | |
| 12 | Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway. | 1999 | 108 |
| 13 | 1998 | 46 | |
| 14 | Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models. | 1998 | 86 |
| 15 | A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells. | 1997 | 61 |
| 16 | Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice. | 1996 | 54 |
| 17 | 1993 | 14 | |
| 18 | Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. | 1993 | 116 |
| 19 | Expression of LDL receptor on tumor cells induced by growth factors. | 1991 | 6 |
| 20 | 1990 | 30 |
About Andreas Menrad
Andreas Menrad is a scholar working on Immunology and Allergy, Urology, Cancer Research, Immunology and Oncology, having authored 30 papers that have together received 1.5k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (7 papers), Cell Adhesion Molecules Research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Cancer, Hypoxia, and Metabolism (4 papers), Hair Growth and Disorders (3 papers), Peptidase Inhibition and Analysis (3 papers), Immunotherapy and Immune Responses (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Immunology and Allergy (162 citations), Urology (163 citations), Oncology (513 citations), Cancer Research (206 citations) and Immunology (267 citations). Andreas Menrad has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Michael Schirner, Martin R. Schneider, Hans D. Menssen, Meenhard Herlyn, Ralf Paus, Gerhard Siemeister, Jens Hoffmann, David W. Speicher, Bori Handjiski and Ulrich Klar. Their work appears in journals such as Journal of Investigative Dermatology, The FASEB Journal, JNCI Journal of the National Cancer Institute, Clinical Cancer Research and Expert Opinion on Therapeutic Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.